Chengdu Kanghua Biological Products Co., Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 634.44 million compared to CNY 659.77 million a year ago. Revenue was CNY 634.44 million compared to CNY 659.77 million a year ago.

Net income was CNY 248.2 million compared to CNY 315.68 million a year ago. Basic earnings per share from continuing operations was CNY 1.8558 compared to CNY 2.3542 a year ago. Diluted earnings per share from continuing operations was CNY 1.8554 compared to CNY 2.3542 a year ago.